United States · FDA National Drug Code directory

BUPROPION HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 16729-444_4092a3ea-403d-7a91-e063-6394a90a8ddf
Product NDC: 16729-444
Form: TABLET, EXTENDED RELEASE
Composition / generic term: BUPROPION HYDROCHLORIDE
Labeler: Accord Healthcare Inc.
Marketing category: ANDA
Marketing start / end (source format): 20190325
Source listing expiry: 20261231

Source-listed ingredients

BUPROPION HYDROCHLORIDE — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-444-10) · 16729-444-10
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-444-16) · 16729-444-16

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →